Life Science Company News

Reset
Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Dr. Gary Nakhuda to Present Insights on Mosaic Embryo Transfer at CFAS Annual Meeting 2023

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

lululemon's Third Annual Global Wellbeing Report Reveals the 'Wellbeing Dilemma': Though People Are Increasingly Prioritizing It, It's Not Improving

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERU

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023
Related companies:  Filament Health Corp.

VEDU Announces New Business Development and Management Team Changes

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

New Manulife Data Shows Spike in Adult ADHD Diagnosis

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

Asthma Canada and Fellowes Canada Announces Partnership in Support of Community Health

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

MaRS teams up with Elevate to showcase innovators in sustainability and AI at the 2023 Festival

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023
Related companies:  MaRS Discovery District

Novozymes OneHealth and Juneyao Health announced a strategic partnership at 14th ACN

Read more ››
By: GlobeNewswire - 21 Sep 2023

Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Faron Pharmaceuticals Oy

Mendus to present novel data supporting the broad potential of its proprietary cancer vaccine platform at CICON23

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Mendus AB

Key Outcomes From FDA Type A Meeting and Mesoblast Next Steps to Achieve RYONCIL Approval

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Mesoblast Limited

Apnimed Announces First Patient Dosed in LunAIRo, the First Phase 3 Clinical Study of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Apnimed, Inc.

Coave Therapeutics Appoints Genetic Medicine Expert Lolita Petit, PhD as Chief Scientific Officer

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  Coave Therapeutics

MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Burns in Adults

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  MediWound Ltd.

LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy

Read more ››
By: GlobeNewswire - 21 Sep 2023
Related companies:  LifeMD, Inc

Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023
Related companies:  Yuyu Pharma, Inc.

Reshaping Oncology Research and Consulting services: How DLI Empowers Every Step of the Journey | Disease Landscape Insights

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncology

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023
Related companies:  CARsgen Therapeutics Holdings Limited

United Imaging Healthcare debuts Next-Generation PET/CT Systems, the uMI Panorama Family, and the Integrated Molecular Technology Platform at EANM

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Read more ››
By: PR Newswire Association LLC. - 21 Sep 2023
Related companies:  Antengene Corporation
Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »